BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32981060)

  • 1. Outcomes of the Bethesda system for reporting thyroid cytopathology: Real-life experience.
    Avior G; Dagan O; Shochat I; Frenkel Y; Tessler I; Meir A; Jaffe A; Cohen O
    Clin Endocrinol (Oxf); 2021 Mar; 94(3):521-527. PubMed ID: 32981060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of the Bethesda system for reporting thyroid cytopathology in community- vs. institution-performed cytology.
    Tessler I; Cohen O; Shochat I; Teitelbaum T; Dagan O; Meir A; Jaffe A; Avior G
    Am J Otolaryngol; 2022; 43(2):103341. PubMed ID: 34968817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
    Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
    Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
    [No Abstract]   [Full Text] [Related]  

  • 4. Consistency in the Distribution of Bethesda System for Reporting Thyroid Cytology Categories Over 9 Years: A Single Institute, Retrospective Study.
    Harris M; Zloczower E; Pinhas S; Allon R; Zornitzki T; Malka L; Cohen Y; Lahav Y; Cohen O
    Endocr Pract; 2024 Jun; 30(6):546-550. PubMed ID: 38570016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
    Yaprak Bayrak B; Eruyar AT
    BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology.
    Chen JC; Pace SC; Chen BA; Khiyami A; McHenry CR
    Surgery; 2012 Dec; 152(6):1037-44. PubMed ID: 23040711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the Bethesda Classification for Thyroid Fine-Needle Aspiration: Institutional Experience and Meta-analysis.
    Krauss EA; Mahon M; Fede JM; Zhang L
    Arch Pathol Lab Med; 2016 Oct; 140(10):1121-31. PubMed ID: 27684984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Bethesda System and the ACR TIRADS in an Endemic Goiter Region.
    Karaagac M; Sarigoz T; Ertan T; Topuz O
    Endocr Res; 2020 Nov; 45(4):226-232. PubMed ID: 32729365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Bethesda System for Reporting Thyroid Cytopathology in a Danish tertiary centre.
    Madsen SH; Jespersen ML; Bonnema SJ; Rolighed L; Swan KZ
    Dan Med J; 2024 May; 71(6):. PubMed ID: 38847411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Correlation of Thyroid Nodule Cytology with Molecular Profiling-a Single-Center Experience.
    Tessler I; Shochat I; Cohen O; Meir A; Avior G
    Endocr Pathol; 2021 Dec; 32(4):480-488. PubMed ID: 34086262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tertiary center's experience with second review of 3885 thyroid cytopathology specimens.
    Olson MT; Boonyaarunnate T; Aragon Han P; Umbricht CB; Ali SZ; Zeiger MA
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1450-7. PubMed ID: 23436916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating the 'CUT score' risk stratification tool for indeterminate thyroid nodules using the Bethesda system for reporting thyroid cytopathology.
    Pinhas S; Tessler I; Bizer LP; Khalilia K; Warman M; Adi M; Halperin D; Cohen O
    Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):383-390. PubMed ID: 33844064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the surgical treatment of thyroid nodules.
    Richmond BK; O'Brien BA; Mangano W; Thompson S; Kemper S
    Am Surg; 2012 Jun; 78(6):706-10. PubMed ID: 22643269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of the bethesda system for reporting thyroid cytopathology: interobserver concordance and reclassification of previously inconclusive aspirates.
    Pathak P; Srivastava R; Singh N; Arora VK; Bhatia A
    Diagn Cytopathol; 2014 Nov; 42(11):944-9. PubMed ID: 24692395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Bethesda System for Reporting Thyroid Cytopathology in the Eastern Province of Saudi Arabia: phase I pilot retrospective analysis.
    Al-Abbadi MA; Shareef SQ; Ali JA; Yousef MM
    Acta Cytol; 2013; 57(5):481-8. PubMed ID: 24021940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features on Revised Bethesda System Malignancy Rates at a Single Institution.
    Linhares SM; Whitfield BW; Lee AF; Gordillo D; Picado O; Jeraq M; Farrá JC; Lew JI
    J Surg Res; 2020 Nov; 255():152-157. PubMed ID: 32563006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid fine-needle aspiration reporting rates and outcomes before and after Bethesda implementation within a combined academic and community hospital system.
    Harvey AM; Mody DR; Amrikachi M
    Arch Pathol Lab Med; 2013 Nov; 137(11):1664-8. PubMed ID: 24168507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indeterminate nodules by the Bethesda system for reporting thyroid cytopathology in Israel: Frequency, and risk of malignancy after reclassification of follicular thyroid neoplasm with papillary-like features.
    Rosenblum RC; Shtabsky A; Marmor S; Trejo L; Yaish I; Barnes S; Yehuda M; Stern N; Silman Z; Tordjman KM
    Eur J Surg Oncol; 2019 Jul; 45(7):1182-1187. PubMed ID: 30928335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda System for Reporting Thyroid Cytopathology.
    Broome JT; Solorzano CC
    Surgery; 2011 Dec; 150(6):1234-41. PubMed ID: 22136846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
    Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
    Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.